Resveratrol improves hepatic insulin signaling and reduces the inflammatory response in streptozotocin-induced diabetes

Gene

Volumn 570, Issue 2, 2015, Pages 213-220

  Sadi, Gökhan ^a   Pektaş, Mehmet Bilgehan ^b   Koca, Halit Bugra ^b   Tosun, Murat ^b   Koca, Tulay ^c  

^a KARAMANOGLU MEHMETBEY UNIVERSITY   (Turkey)

^b AFYON KOCATEPE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Diabetes; Insulin signaling; Liver; PI3K Akt; Resistin; Resveratrol

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LIPID; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RESISTIN; RESVERATROL; STREPTOZOCIN; TRANSCRIPTION FACTOR FKHRL1; TRIACYLGLYCEROL; XANTHINE OXIDASE; STILBENE DERIVATIVE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INFLAMMATION; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIVER; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; INFLAMMATION; INSULIN; LIVER; MALE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; STILBENES; STREPTOZOCIN;

EID: 84938977061     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.06.019     Document Type: Article

References (36)

1. Ashraf H., Zare S. Preventive effects of aqueous extract of Berberis integerrima Bge. Root on liver injury induced by diabetes mellitus (type 1) in rats. Iran. J. Pharm. Res. IJPR 2015, 14:335-343.
2. Aydin M., Çelik S. Effects of lycopene on plasma glucose, insulin levels, oxidative stress, and body weights of streptozotocin-induced diabetic rats. Turk. J. Med. Sci. 2012, 42:1406-1413. 10.3906/sag-1202-44.
3. Babacanoglu C., Yildirim N., Sadi G., Pektas M.B., Akar F. Resveratrol prevents high-fructose corn syrup-induced vascular insulin resistance and dysfunction in rats. Food Chem. Toxicol. 2013, 60:160-167. 10.1016/j.fct.2013.07.026.
4. Barthel A., Schmoll D., Krüger K.D., Bahrenberg G., Walther R., Roth R.A., Joost H.G. Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells. Biochem. Biophys. Res. Commun. 2001, 285:897-902. 10.1006/bbrc.2001.5261.
5. Baur J.A. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech. Ageing Dev. 2010, 131:261-269. 10.1016/j.mad.2010.02.007.
6. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., Tran H., Ross S.E., Mostoslavsky R., Cohen H.Y., Hu L.S., Cheng H.-L., Jedrychowski M.P., Gygi S.P., Sinclair D.A., Alt F.W., Greenberg M.E. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004, 303:2011-2015. 10.1126/science.1094637.
7. Chang C.-C., Chang C.-Y., Huang J.-P., Hung L.-M. Effect of resveratrol on oxidative and inflammatory stress in liver and spleen of streptozotocin-induced type 1 diabetic rats. Chin. J. Physiol. 2012, 55:192-201. 10.4077/CJP.2012.BAA012.
8. Chen W.-P., Chi T.-C., Chuang L.-M., Su M.-J. Resveratrol enhances insulin secretion by blocking K(ATP) and K(V) channels of beta cells. Eur. J. Pharmacol. 2007, 568:269-277. 10.1016/j.ejphar.2007.04.062.
9. Chen Y., Wang Y., Zhang J., Sun C., Lopez A. Berberine improves glucose homeostasis in streptozotocin-induced diabetic rats in association with multiple factors of insulin resistance. ISRN Endocrinol. 2011, 2011:1-8. 10.5402/2011/519371.
10. Deng J.-Y., Hsieh P.-S., Huang J.-P., Lu L.-S., Hung L.-M. Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways. Diabetes 2008, 57:1814-1823. 10.2337/db07-1750.
11. Dolinsky V.W., Rueda-Clausen C.F., Morton J.S., Davidge S.T., Dyck J.R.B. Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted. Diabetes 2011, 60:2274-2284. 10.2337/db11-0374.
12. Fujimoto M., Shimizu N., Kunii K., Martyn J.A.J., Ueki K., Kaneki M. A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 2005, 54:1340-1348.
13. Hamadi N., Mansour A., Hassan M.H., Khalifi-Touhami F., Badary O. Ameliorative effects of resveratrol on liver injury in streptozotocin-induced diabetic rats. J. Biochem. Mol. Toxicol. 2012, 26:384-392. 10.1002/jbt.21432.
14. Hong H.J., Kang W., Kim D.G., Lee D.H., Lee Y., Han C.-H. Effects of resveratrol on the insulin signaling pathway of obese mice. J. Vet. Sci. 2014, 15:179-185.
15. Jamaluddin M.S., Weakley S.M., Yao Q., Chen C. Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br. J. Pharmacol. 2012, 165:622-632. 10.1111/j.1476-5381.2011.01369.x.
16. Jimenez-Gomez Y., Mattison J.A., Pearson K.J., Martin-Montalvo A., Palacios H.H., Sossong A.M., Ward T.M., Younts C.M., Lewis K., Allard J.S., Longo D.L., Belman J.P., Malagon M.M., Navas P., Sanghvi M., Moaddel R., Tilmont E.M., Herbert R.L., Morrell C.H., Egan J.M., Baur J.A., Ferrucci L., Bogan J.S., Bernier M., de Cabo R. Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. Cell Metab. 2013, 18:533-545. 10.1016/j.cmet.2013.09.004.
17. Kang W., Hong H.J., Guan J., Kim D.G., Yang E.-J., Koh G., Park D., Han C.H., Lee Y.-J., Lee D.-H. Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents. Metabolism 2012, 61:424-433. 10.1016/j.metabol.2011.08.003.
18. Kim D.H., Perdomo G., Zhang T., Slusher S., Lee S., Phillips B.E., Fan Y., Giannoukakis N., Gramignoli R., Strom S., Ringquist S., Dong H.H. FoxO6 integrates insulin signaling with gluconeogenesis in the liver. Diabetes 2011, 60:2763-2774. 10.2337/db11-0548.
19. Kobayashi Y., Furukawa-Hibi Y., Chen C., Horio Y., Isobe K., Ikeda K., Motoyama N. SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. Int. J. Mol. Med. 2005, 16:237-243.
20. Liu F., Yang T., Wang B., Zhang M., Gu N., Qiu J., Fan H., Zhang C., Fei L., Pan X., Guo M., Chen R., Guo X. Resistin induces insulin resistance, but does not affect glucose output in rat-derived hepatocytes. Acta Pharmacol. Sin. 2008, 29:98-104. 10.1111/j.1745-7254.2008.00709.x.
21. Liu M.-H., Yuan C., He J., Tan T.-P., Wu S.-J., Fu H.-Y., Liu J., Yu S., Chen Y.-D., Le Q.-F., Tian W., Hu H.-J., Zhang Y., Lin X.-L. Resveratrol protects PC12 cells from high glucose-induced neurotoxicity via PI3K/Akt/FoxO3a pathway. Cell. Mol. Neurobiol. 2015, 35:513-522. 10.1007/s10571-014-0147-5.
22. Lizcano J.M., Alessi D.R. The insulin signalling pathway. Curr. Biol. 2002, 12:R236-R238.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
24. Lu M., Patsouris D., Li P., Flores-Riveros J., Frincke J.M., Watkins S., Schenk S., Olefsky J.M. A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E1036-E1048. 10.1152/ajpendo.00668.2009.
25. Muse E.D., Lam T.K.T., Scherer P.E., Rossetti L. Hypothalamic resistin induces hepatic insulin resistance. J. Clin. Invest. 2007, 117:1670-1678. 10.1172/JCI30440.
26. Nojiri T., Kurano M., Tokuhara Y., Ohkubo S., Hara M., Ikeda H., Tsukamoto K., Yatomi Y. Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma, liver and kidneys in streptozotocin-induced diabetic mice. J. Diabetes Invest. 2014, 5:639-648. 10.1111/jdi.12232.
27. Sadi G., Bozan D., Yildiz H.B. Redox regulation of antioxidant enzymes: post-translational modulation of catalase and glutathione peroxidase activity by resveratrol in diabetic rat liver. Mol. Cell. Biochem. 2014, 393:111-122. 10.1007/s11010-014-2051-1.
28. Sadi G., Baloglu M.C., Pektas M.B. Differential gene expression in liver tissues of streptozotocin-induced diabetic rats in response to resveratrol treatment. PLoS One 2015, 10(4):e0124968. 10.1371/journal.pone.0124968.
29. Schmatz R., Perreira L.B., Stefanello N., Mazzanti C., Spanevello R., Gutierres J., Bagatini M., Martins C.C., Abdalla F.H., da Silva Daci, Serres J., Zanini D., Vieira J.M., Cardoso A.M., Schetinger M.R., Morsch V.M. Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie 2012, 94:374-383. 10.1016/j.biochi.2011.08.005.
30. Schmoll D., Walker K.S., Alessi D.R., Grempler R., Burchell A., Guo S., Walther R., Unterman T.G. Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J. Biol. Chem. 2000, 275:36324-36333. 10.1074/jbc.M003616200.
31. Skov V., Knudsen S., Olesen M., Hansen M.L., Rasmussen L.M. Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes. Cardiovasc. Diabetol. 2012, 11:15. 10.1186/1475-2840-11-15.
32. Symons J.D., McMillin S.L., Riehle C., Tanner J., Palionyte M., Hillas E., Jones D., Cooksey R.C., Birnbaum M.J., McClain D.A., Zhang Q.-J., Gale D., Wilson L.J., Abel E.D. Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circ. Res. 2009, 104:1085-1094. 10.1161/CIRCRESAHA.108.189316.
33. Wang X., Li J., Liu L., Hu N., Jin S., Liu C., Mei D., Liu X. Tissue cholesterol content alterations in streptozotocin-induced diabetic rats. Acta Pharmacol. Sin. 2012, 33:909-917. 10.1038/aps.2012.50.
34. Xia N., Strand S., Schlufter F., Siuda D., Reifenberg G., Kleinert H., Förstermann U., Li H. Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol. Nitric Oxide 2013, 32:29-35. 10.1016/j.niox.2013.04.001.
35. Yu W., Wan Z., Qiu X.-F., Chen Y., Dai Y.-T. Resveratrol, an activator of SIRT1, restores erectile function in streptozotocin-induced diabetic rats. Asian J. Androl. 2013, 15:646-651. 10.1038/aja.2013.60.
36. Zhou L., Li Y., Xia T., Feng S., Chen X., Yang Z. Resistin overexpression impaired glucose tolerance in hepatocytes. Eur. Cytokine Netw. 2006, 17:189-195.